CNPAX
Price
$72.99
Change
-$0.98 (-1.32%)
Updated
Jul 13 closing price
Net Assets
170.23B
MECFX
Price
$16.79
Change
-$0.12 (-0.71%)
Updated
Jul 13 closing price
Net Assets
136.53M
Interact to see
Advertisement

CNPAX vs MECFX

CNPAX vs MECFX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. MECFX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Hold and MECFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 170B vs. MECFX (137M). CNPAX pays higher dividends than MECFX: CNPAX (0.95) vs MECFX (0.39). CNPAX was incepted earlier than MECFX: CNPAX (24 years) vs MECFX (10 years). MECFX (1.00) is less costly to investors than CNPAX (0.74). MECFX is a more actively managed with annual turnover of: 33.00 vs. CNPAX (23.00). CNPAX has a lower initial minimum investment than MECFX: CNPAX (250) vs MECFX (1000000). CNPAX annual gain was more profitable for investors over the last year : 7.37 vs. MECFX (6.64). CNPAX return over 5 years is better than : 13.82 vs. MECFX (5.35).
CNPAXMECFXCNPAX / MECFX
Total Expense Ratio0.740.9082%
Annual Report Gross Expense Ratio0.741.0074%
Fund Existence24 years10 years-
Gain YTD5.3257.69769%
Front Load4%N/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets170B137M124,088%
Annual Yield % from dividends0.950.39246%
Returns for 1 year7.376.64111%
Returns for 3 years34.1730.49112%
Returns for 5 years13.825.35258%
Returns for 10 years115.9168.73169%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBDIX200.49N/A
N/A
Franklin Biotechnology Discovery A
VGHCX206.44N/A
N/A
Vanguard Health Care Inv
SCETX9.22N/A
N/A
Virtus Ceredex Small-Cap Value Eq I
SEFCX14.37N/A
N/A
SEI International Equity Y (SIT)
VREMX7.87N/A
N/A
Virtus SGA Emerging Markets Equity R6